79th United Nations General Assembly Meeting 2024

The 79th UNGA Session, held on September 10, 2024, saw 193 member countries participate in a general debate focusing on peace, sustainable development, and human dignity for present and future generations.

Overview and Key Details of the 79th UNGA Session

Commenced on September 10, 2024
General debate: September 24-30, 2024
Theme: "Leaving no one behind: acting together for the advancement of peace, sustainable development, and human dignity for present and future generations"
President: Philemon Yang from Cameroon
193 member countries participate, each with equal voting rights
Decisions carry political weight but are not legally binding
Roster includes 87 heads of state, 3 vice-presidents, 2 crown princes, 45 heads of government, and other delegates
Speech time limit: 15 minutes (voluntary)

Major Events and High-Level Meetings

Summit of the Future: September 22-23, 2024
- Aims to adopt key documents including a pact for the future, declaration on future generations, and global digital compact
High-level plenary on sea level rise threats: September 25, 2024
International Day for the Total Elimination of Nuclear Weapons commemoration: September 26, 2024
High-level meeting on antimicrobial resistance: September 26, 2024
Traditional speaking order: Brazil first, followed by the United States as host country

Key Issues and Expected Discussions

War in Gaza: Calls for ceasefire; addresses by Israeli PM Netanyahu and Palestinian President Abbas on September 26
Ukraine Conflict: President Zelenskiy to speak on September 25; Russian Foreign Minister Lavrov on September 28
Climate Change: Urgent appeals from vulnerable nations, especially small island states
UN Security Council Reform: Discussions on expanding membership and limiting veto powers
Global Economic Governance: Reforms for the World Bank, IMF, and digital governance
Sustainable Development: Focus on leaving no one behind and ensuring human dignity
Nuclear Disarmament: Commemorating efforts towards total elimination of nuclear weapons
Antimicrobial Resistance: Addressing global health concerns

SEBI Action on Jane Street

In one of the most significant regulatory crackdowns in Indian financial history, the SEBI action on Jane Street has grabbed headlines and raised critical discussions around foreign investment, ma

Rwanda-Congo Peace Deal

In a major diplomatic development, Rwanda and the Democratic Republic of Congo (DRC) signed the historic Rwanda-Congo peace deal in 2025. This US-brokered peace agreement aims to end deca

India Rejects SCO Joint Statement

India rejects SCO joint statement – this powerful decision echoed globally after India’s Defence Minister refused to sign the final declaration at the SCO 2025 Summit in Qingdao, China

Unsafe Generic Chemotherapy Drugs

Recent investigations have uncovered serious quality issues in generic chemotherapy drugs used for cancer treatment across more than 100 countries. This has raised alarms over the safety, effe

NATO Defence Spending 2025

The NATO defence spending 2025 summit has marked a historic turning point in the alliance’s approach to global defence and military funding. Under the leadership of former U.S. President

Operation Bashayer Al-Fath

On June 23, 2025, the Middle East witnessed a major escalation as Iran launched Operation Bashayer Al-Fath, a powerful missile assault targeting the US Al-Udeid Air Base in Qatar. This developm

GENIUS Act 2025 Highlights

The GENIUS Act 2025, passed by the US Senate in June 2025, represents a significant legislative step in cryptocurrency regulation, with a widespread impact on stablecoins, digi

US-Iran Nuclear Conflict 2025

On June 22, 2025, the United States launched targeted airstrikes on three major Iranian nuclear facilities—Fordow, Isfahan, and Natanz—escalating what is now widely recognized as the U

Iran Uranium Enrichment

The ongoing tension between Iran, Israel, and the United States has taken a serious turn, primarily due to Iran's uranium enrichment issue. The situation surrounding Iran’s Fordow nuclea

Yeztugo HIV Injection

In a historic development in the fight against HIV, the United States Food and Drug Administration (US FDA) has approved Yeztugo HIV injection—a revolutionary drug for the long-acting preven